Search results

  1. SNT Gatchaman

    What Can We Learn Four Years On? A Multi-Centre Service Evaluation Exploring Symptoms, Functional Impact, Recovery and Care Pathways…, 2025, Lee+

    What Can We Learn Four Years On? A Multi-Centre Service Evaluation Exploring Symptoms, Functional Impact, Recovery and Care Pathways in Long Covid BACKGROUND Long Covid (LC) is associated with long-term health impacts that require ongoing support from healthcare services. We aimed to gain...
  2. SNT Gatchaman

    Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway…, 2014, Bakken+

    The related thread we have is Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression, 2019, Jin+ [two age groups]. Tag made for two age peaks to keep track.
  3. SNT Gatchaman

    Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway…, 2014, Bakken+

    Older paper (2014) predating S4ME, but relevant for review due to — See general discussion thread The two age peaks in onset of ME/CFS.
  4. SNT Gatchaman

    MRC/NIHR DecodeME Showcase meeting online and in person Nov 6th

    I've made a thread at Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008-2012 (2014)
  5. SNT Gatchaman

    Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway…, 2014, Bakken+

    Merged thread ------------------- Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008-2012 BACKGROUND The aim of the current study was to estimate sex-and age-specific incidence rates of chronic fatigue...
  6. SNT Gatchaman

    Experiences of accessing primary care by those living with long Covid in New Zealand: A qualitative analysis, 2025, Rhodes et al.

    Audio link: https://www.rnz.co.nz/national/programmes/ninetonoon/audio/2019011538/otago-survey-finds-healthcare-failing-long-covid-patients
  7. SNT Gatchaman

    Daratumumab, isatuximab (CD38 drugs)

    That paper's cohort are patients with myeloma, and they are characterised as extensively pre-treated. Could a reduced CD38 expression on plasma cells more generally be an environmental effect (eg a precursor requirement) before you can even get to the clonal expansion seen in myeloma? Ie is it...
  8. SNT Gatchaman

    Membrane integrity changes upon viral infection activate sphingomyelinase SMPDL3B to restrict cGAS-STING signaling via cGAMP degradation, 2025, Wang+

    Membrane integrity changes upon viral infection activate sphingomyelinase SMPDL3B to restrict cGAS-STING signaling via cGAMP degradation The cyclic guanosine monophosphate (GMP)-AMP synthase (cGAS)-cyclic GMP-AMP (cGAMP)-stimulator of interferon genes (STING) pathway mediates antiviral innate...
  9. SNT Gatchaman

    RETRACTED: Post–COVID-19 Condition in Children, 2023, Hahn et al

    Just because it was referenced on Bsky today here also is the thread from 10 months ago from Mark Ungrin PhD. This all sounds depressingly familiar @dave30th.
  10. SNT Gatchaman

    scRNA-seq reveals persistent aberrant differentiation of nasal epithelium driven by TNFα and TGFβ in post-COVID syndrome, 2025, Reddy et al.

    [8] is Severity, predictors and clinical correlates of Post-COVID syndrome PCS in Germany: A prospective, multi-centre, population-based cohort study (2022) It's invasive. Also not pleasant, if any of you like me have had this sort of thing done. Perhaps ethical approval couldn't include...
  11. SNT Gatchaman

    Serum GDF15 as a supportive biomarker in female fibromyalgia patients based on a prospective case-control study, 2025, Yigit et al

    Growth Differentiation Factor-15 Is Considered a Predictive Biomarker of Long COVID in Non-hospitalized Patients (2024) Charting the Circulating Proteome in ME/CFS: Cross System Profiling and Mechanistic insights (2025) Heightened innate immunity may trigger chronic inflammation, fatigue...
  12. SNT Gatchaman

    SARS-CoV-2 spike triggers TLR7-dependent endolysosome dysfunction and senescence in human astrocytes, 2025, Hasler et al.

    SARS-CoV-2 spike triggers TLR7-dependent endolysosome dysfunction and senescence in human astrocytes SARS-CoV-2 infection is associated with long-lasting neuropsychiatric and cognitive symptoms, collectively referred to as neuro-PASC. Emerging studies indicates that accelerate brain aging and...
  13. SNT Gatchaman

    Investigating apoptosis in peripheral blood mononuclear cells among the elderly in the post-COVID-19 era, 2025, Abiri and Hemmatian

    Investigating apoptosis in peripheral blood mononuclear cells among the elderly in the post-COVID-19 era Abiri, Elaheh; Hemmatian, Najmeh BACKGROUND AND AIM The COVID-19 pandemic has left a lasting imprint on immune function, particularly in the elderly—a population already vulnerable to...
Back
Top Bottom